ArticleNature communications2022

Administration of broadly neutralizing anti-HIV-1 antibodies at ART initiation maintains long-term CD8

Miriam Rosás-Umbert et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.